Drugs/Recall·openFDA/drug

Sterling Pharmaceutical Services LLC — Class II: Lubricant Eye Drops-Cameron Pharmaceuticals, Carboxymethylcellulose Sodium 0.5%, Eye Lubri

MediumPublished Sep 30, 2026· AI-analyzed Oct 6, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Sterling Pharmaceutical Services LLC has initiated a Class II recall for Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%) distributed by Cameron Pharmaceuticals due to a lack of assurance of sterility. The recall involves 15 mL bottles (NDC 42494-448-05) and is currently classified as ongoing.

Who it affects

This affects Sterling Pharmaceutical Services LLC, Cameron Pharmaceuticals, LLC, and entities involved in the distribution, quality oversight, and clinical administration of ophthalmic lubricants.

Why it matters

A Class II recall due to lack of sterility assurance in an ophthalmic product indicates a potential risk of infection or injury, though the health consequences are typically temporary or reversible. For regulatory professionals, this suggests a breakdown in aseptic processing or sterility testing protocols at the manufacturing site, likely requiring a comprehensive root cause analysis and corrective actions to prevent recurrence.

Practical takeaway

QA and manufacturing teams should verify sterility assurance protocols for ophthalmic products and assess current inventories for NDC 42494-448-05. Regulatory departments should monitor the status of this ongoing recall to ensure proper reporting of any associated adverse events.

FDA source material

Class II. Reason: Lack of Assurance of Sterility. Product: Lubricant Eye Drops-Cameron Pharmaceuticals, Carboxymethylcellulose Sodium 0.5%, Eye Lubricant, 0.5 FL OZ (15 mL) bottles, Distributed by Cameron Pharmaceuticals, LLC, Louisville, KY, 40245, NDC 42494-448-05. Firm: Sterling Pharmaceutical Services LLC (Dupo IL United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.